Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlencore Regulatory News (GLEN)

Share Price Information for Glencore (GLEN)

Share Price is delayed by 15 minutes
Get Live Data
574.10    -21.00 (-3.53%)
Bid:
573.70
Ask:
573.80
Spread: 0.10 (0.017%)
Market Cap: £67.26b
GLEN Live PriceLast checked at - London Stock Exchange

Intraday Glencore Share Chart

Form 8.3 - Glencore PLC

20 Jan 2026 15:20

RNS Number : 6360P
BlackRock Group
20 January 2026
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

(a) Full name of discloser:

BlackRock, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Glencore plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

19 January 2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes, Rio Tinto plc and Rio Tinto Limited

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary NPV

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

836,960,532

7.12%

0

0.00%

(2) Cash-settled derivatives:

 

2,024,583

0.01%

8,849,695

0.07%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00%

5,000,000

0.04%

 

TOTAL:

838,985,115

7.14%

13,849,695

0.11%

*BlackRock, Inc. does not have voting authority over 57,529,114 shares, however investment discretion is retained.

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary NPV

Purchase

505,246

GBP 4.8105

Ordinary NPV

Purchase

36,926

GBP 4.8144

Ordinary NPV

Purchase

629,787

GBP 4.8181

Ordinary NPV

Sale

102,231

GBP 4.8013

Ordinary NPV

Sale

39,742

GBP 4.8105

Ordinary NPV

Sale

659,737

GBP 4.8121

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Ordinary NPV

CFD

Increasing long

36,826

GBP 4.8105

Ordinary NPV

CFD

Reducing short

175,603

GBP 4.8105

Ordinary NPV

CFD

Increasing short

184,983

GBP 4.8105

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

ADR's*

Transfer In of ADR's

13,024

Ordinary NPV

Transfer In of Shares

427,339

*Please note each ADR converts to 2 Ordinary shares

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

Yes

 

Date of disclosure:

20 January 2026

Contact name:

Jana Blumenstein

Telephone number:

+44 20 7743 3650

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

.

 

 

 

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

 

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

Full name of person making disclosure:

BlackRock, Inc.

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

Glencore plc

 

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

 

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Ordinary NPV

Purchased Put Option

Purchased

5,000,000

GBP 4.6000

American

20/02/2026

 

3. AGREEMENTS TO PURCHASE OR SELL ETC.

 

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

 

 

 

 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

 

The currency of all prices and other monetary amounts should be stated.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETPPUWPGUPQGWU
Date   Source Headline
29th May 20245:09 pmRNSNotification of Transaction of PDMR
29th May 20245:05 pmRNSNotification of Transaction of PDMR
29th May 20244:46 pmRNSResults of 2024 AGM
17th May 20247:00 amRNSGlencore publishes 2023 Sustainability Report
10th May 20242:09 pmRNS2024 H1 Distribution
2nd May 20248:12 amRNSXS1799614232 Glencore Convertible
30th Apr 202412:00 pmRNSNotice of Annual General Meeting
30th Apr 20247:00 amRNSFirst Quarter Production Report 2024
21st Mar 20247:00 amRNSBoard Changes
20th Mar 20248:43 amRNSPublication of 2nd Climate Action Transition Plan
20th Mar 20248:41 amRNSPublication of 2023 Annual Report
21st Feb 202411:12 amRNS2024 Distribution timetable
21st Feb 20247:00 amRNSPreliminary Results 2023
1st Feb 20247:53 amRNSTotal Voting Rights
1st Feb 20247:00 amRNSFull Year 2023 Production Report
25th Jan 20249:00 amRNSNotice of 2023 Preliminary Results
12th Jan 20244:36 pmRNSCompletion of 2nd part of share buy-back programme
12th Jan 20249:30 amRNSTransaction in Own Shares
11th Jan 20245:00 pmRNSTransaction in Own Shares
10th Jan 20244:50 pmRNSTransaction in Own Shares
9th Jan 20244:56 pmRNSTransaction in Own Shares
8th Jan 20245:03 pmRNSTransaction in Own Shares
5th Jan 20244:58 pmRNSTransaction in Own Shares
4th Jan 20244:55 pmRNSTransaction in Own Shares
3rd Jan 20244:52 pmRNSTransaction in Own Shares
2nd Jan 20248:02 amRNSTotal Voting Rights
29th Dec 20231:10 pmRNSTransaction in Own Shares
28th Dec 20235:18 pmRNSTransaction in Own Shares
27th Dec 20235:21 pmRNSTransaction in Own Shares
22nd Dec 20231:24 pmRNSTransaction in Own Shares
21st Dec 20235:32 pmRNSTransaction in Own Shares
20th Dec 20235:27 pmRNSTransaction in Own Shares
19th Dec 20235:29 pmRNSTransaction in Own Shares
19th Dec 20231:30 pmRNS2024 Corporate Calendar
18th Dec 20235:38 pmRNSTransaction in Own Shares
15th Dec 20235:04 pmRNSTransaction in Own Shares
14th Dec 20234:54 pmRNSTransaction in Own Shares
13th Dec 20235:05 pmRNSTransaction in Own Shares
13th Dec 202312:00 pmRNSAGM climate vote shareholder consultation update
12th Dec 20234:57 pmRNSTransaction in Own Shares
11th Dec 20235:50 pmRNSTransaction in Own Shares
11th Dec 202311:44 amRNSDirector declaration
8th Dec 20234:53 pmRNSTransaction in Own Shares
7th Dec 20235:12 pmRNSTransaction in Own Shares
6th Dec 20235:46 pmRNSTransaction in Own Shares
5th Dec 20235:08 pmRNSTransaction in Own Shares
5th Dec 20231:58 pmRNSCancellation of Treasury shares
4th Dec 20235:06 pmRNSTransaction in Own Shares
1st Dec 20235:41 pmRNSTransaction in Own Shares
1st Dec 20234:00 pmRNSGlencore purchase of stakes in Alunorte and MRN

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.